These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18329269)

  • 21. New adenosine A2A receptor antagonists: actions on Parkinson's disease models.
    Pinna A; Volpini R; Cristalli G; Morelli M
    Eur J Pharmacol; 2005 Apr; 512(2-3):157-64. PubMed ID: 15840400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
    Gillespie RJ; Bamford SJ; Botting R; Comer M; Denny S; Gaur S; Griffin M; Jordan AM; Knight AR; Lerpiniere J; Leonardi S; Lightowler S; McAteer S; Merrett A; Misra A; Padfield A; Reece M; Saadi M; Selwood DL; Stratton GC; Surry D; Todd R; Tong X; Ruston V; Upton R; Weiss SM
    J Med Chem; 2009 Jan; 52(1):33-47. PubMed ID: 19072055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
    Vu CB; Peng B; Kumaravel G; Smits G; Jin X; Phadke D; Engber T; Huang C; Reilly J; Tam S; Grant D; Hetu G; Chen L; Zhang J; Petter RC
    J Med Chem; 2004 Aug; 47(17):4291-9. PubMed ID: 15294001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines.
    Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Jordan AM; Knight AR; Lerpiniere J; Misra A; Pratt RM; Roffey J; Stratton GC; Upton R; Weiss SM; Williamson DS
    Bioorg Med Chem Lett; 2008 May; 18(9):2924-9. PubMed ID: 18411049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists.
    Shah U; Boyle CD; Chackalamannil S; Neustadt BR; Lindo N; Greenlee WJ; Foster C; Arik L; Zhai Y; Ng K; Wang S; Monopoli A; Lachowicz JE
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4199-203. PubMed ID: 18562199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
    Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Giles PR; Jordan AM; Knight AR; Lawrence A; Lerpiniere J; Misra A; Pratt RM; Todd RS; Upton R; Weiss SM; Williamson DS
    Bioorg Med Chem Lett; 2008 May; 18(9):2920-3. PubMed ID: 18407496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice.
    Azam F; Alkskas IA; Ahmed MA
    Eur J Med Chem; 2009 Oct; 44(10):3889-97. PubMed ID: 19447524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological assessments of potent A
    Kumari N; Agrawal S; Luthra PM
    Neurosci Lett; 2017 Apr; 647():53-60. PubMed ID: 28336342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease.
    Hockemeyer J; Burbiel JC; Müller CE
    J Org Chem; 2004 May; 69(10):3308-18. PubMed ID: 15132536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
    J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discovery and synthesis of novel adenosine receptor (A(2A)) antagonists.
    Matasi JJ; Caldwell JP; Hao J; Neustadt B; Arik L; Foster CJ; Lachowicz J; Tulshian DB
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1333-6. PubMed ID: 15713381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel investigational adenosine A2A receptor antagonists for Parkinson's disease.
    Pinna A
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1619-31. PubMed ID: 19888872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of M3-choline receptor blockade on the ability of muscarinic antagonists to prevent catalepsy induced by haloperidol in rats].
    Kosmachev AB; Beliaev VA; Khrabrova AV; Libman NM; Dolgo-Saburov VB
    Eksp Klin Farmakol; 2001; 64(4):10-2. PubMed ID: 11589099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: highly potent, orally active, adenosine A2A antagonists. Part 1.
    Matasi JJ; Caldwell JP; Zhang H; Fawzi A; Cohen-Williams ME; Varty GB; Tulshian DB
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3670-4. PubMed ID: 15978806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Novel and Selective Adenosine A
    Tian S; Wang X; Li L; Zhang X; Li Y; Zhu F; Hou T; Zhen X
    J Chem Inf Model; 2017 Jun; 57(6):1474-1487. PubMed ID: 28463561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease.
    Trevitt J; Vallance C; Harris A; Goode T
    Pharmacol Biochem Behav; 2009 May; 92(3):521-7. PubMed ID: 19463269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liability.
    Moorjani M; Zhang X; Chen Y; Lin E; Rueter JK; Gross RS; Lanier MC; Tellew JE; Williams JP; Lechner SM; Malany S; Santos M; Ekhlassi P; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J; Slee DH
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1269-73. PubMed ID: 18249540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel 8-(furan-2-yl)-3-substituted thiazolo [5,4-e][1,2,4] triazolo[1,5-c] pyrimidine-2(3H)-thione derivatives as potential adenosine A(2A) receptor antagonists.
    Mishra CB; Barodia SK; Prakash A; Senthil Kumar JB; Luthra PM
    Bioorg Med Chem; 2010 Apr; 18(7):2491-500. PubMed ID: 20303771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists.
    Shah U; Lankin CM; Boyle CD; Chackalamannil S; Greenlee WJ; Neustadt BR; Cohen-Williams ME; Higgins GA; Ng K; Varty GB; Zhang H; Lachowicz JE
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4204-9. PubMed ID: 18558486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activity of trisubstituted adenines as A 2A adenosine receptor antagonists.
    Lambertucci C; Vittori S; Mishra RC; Dal Ben D; Klotz KN; Volpini R; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1443-6. PubMed ID: 18066802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.